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Proliferation and differentiation of hemopoietic progenitor cells in culture lie
under the control of a number of different glycoprotein regulatory molecules
including the colony-stimulating factors (CSFs) (1-6), erythropoietin (7), and
manyoftheinterleukins(8-10, Wong, G. G.,J. S. Witek-Giannoti, P. A. Temple,
R. Kriz, C. Ferenz, R. M. Hewick, S. C. Clark, K. Ikebuchi, and M. Ogawa,
submitted for publication). At present, six of these factors, the genes of which
have been molecularly cloned are, by themselves, capable of supporting hemo-
poietic colony formation in semisolid culture. Granulocytic-CSF (G-CSF)' (12-
14), macrophage-CSF (M-CSF, also known as CSF-1) (15-17), and IL-5 (10) (also
known as eosinophil differentiation factor) all appear to be selective for late
committed progenitors, generating neutrophilic granulocytic, macrophagic, and
eosinophilic granulocytic colonies, respectively (although IL-5 also interacts with
both B and T lymphocytes) (18). The gene for each ofthese cytokines is highly
conserved in evolution such that the respective human and mouse proteins react
withtarget cells from either species. Human IL-6(also knownasBcellstimulatory
factor 2/interferon ,B2) has also recently been found to directly support granu-
locyte/macrophage colony formation in the mouse system, an activity that has
been more difficult to detect with human target cells (Won§, G. G., et al.,
submitted for publication). The multipotent colony stimulating factors granulo-
cyte/macrophagic CSF (19) (GM-CSF) and IL-3 (20-25) support the formation
ofa broader rangeofhemopoietic colony typesthan the other cytokines, but the
activities ofthe human and murine proteins are species specific.
Two of the human cytokines, M-CSF (15-17, 26-29) and IL-6 (Wong, G. G.,
et al., submitted for publication), have proved more effective in supporting
colony formation by murine rather than human hemopoietic progenitors. Puri-
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fled human urinary M-CSF, as well as the recombinant factors derived from two
different human cell lines will efficiently support the formation of pure marine
macrophage colonies, but much higher concentrations are required to elicit even
imal response with human target cells (26-29). Similarly, the CSF activity
of human IL-6 has only been clearly demonstrated using marine target cells. In
the mouse system, a factor designated hemopoietin-I (H-1) has been reported to
act synergistically with many of the CSFs, including M-CSF, to yield enhanced
hemopoietic colony formation (30). This synergistic activity, designated H-1, has
proved to be one of the many biologic activities of IL-1 (8), a factor that by itself
has no CSF activity. Because of the many interesting interactions between the
cytokines, we have investigated the possibility that human macrophage colony
formation might be enhanced using combinations of hemopoietins. Our results
demonstrate that subliminal concentrations of GM-CSF, but not of IL-la, IL-3,
nor G-CSF, render human marrow progenitors responsive to M-CSF in clonal
culture systems and suggest that GM-CSF may prime these cells for the action of
NICSF.
Materials and Methods
Reagents.
￿
Recombinant human (rh) GM-CSF, G-CSF, and M-CSF were expressed from
Chinese hamster ovary (CHO) cells engineered to express high levels of the individual
factors. Homogeneous GM-CSF (3-4 X 10' U/ml) from these cells was kindly provided
by the Genetics Institute Pilot Development Lab (Cambridge, MA). The G-CSF and M-
CSF preparations were crude conditioned media from the respective cell lines. The human
IL-3 preparation was made by transfecting cos-1 with an expression plasmid pXM contain-
ing the human IL-3 gene (kindly provided by Dr. Y:C. Yang) as described elsewhere
(24). Human r1L-Ia is From Biogen, Geneva, Switzerland. A polyclonal antiserum (anti-
M-CSF) was prepared at the Genetics Institute by immunizing rabbits with highly purified
humanrecombinant M-CSF, and was kindly provided by Drs. K. Turner and E. Alderman.
This antiserum was added at a final dilution of 1 :300 to the cultures containing M-CSF
or GM-CSF at the time of plating.
Bone Marrow Colony Assays.
￿
Human bone marrow cells were obtained from healthy
volunteers from the iliac bone with a heparin-containing syringe. Informed consent was
obtained. Cells were separated on a Ficoll-Hypaque gradient (31}, washed twice with PBS,
and further depleted of adherent cells by double incubation in plastic flasks (Falcon
Labware, Oxnard, CA) for I h each in RPMI medium (Gibco, Grand island, NY)
containing 15% FCS (Hyclone, Logan UT). Phagocytic elements were removed with a
sterile magnet after incubation of cells in RPMI/15% FCS containing 5 mg/ml carbonyl
iron for 45 min. Cells were then T cell depleted by double resetting with neuraminidase-
treated sheep erythrocytes and centrifugation on Ficoll-Hypaque gradient (32). 8-12-wk-
old female C3H/HEJ mice (The Jackson Laboratories, Bar Harbor, ME) were used.
Animals were killed by cervical dislocation. Bone marrow cellswere obtained from femora,
cleared of surrounding tissue, and opened at both ends with a scalpel. The marrow plug
ejected into RPM1 medium using a syringe connected to the femur with a 20-gauge
needle. Cells were aspirated several times through the needle to obtain a single-cell
suspension. Cells were then depleted of adherent and phagocyticcellsas described for t
human bone marrow cells. 2.5 X 10' human cells and 6 X 10' mouse cells, separated as
described above, were plated in 35-mm Petri dishes (Corning Glass Works, Corning, NY)
at a final volume of I ml/plate, in Iscove's modified Dulbecco'smedium (Gibco) containing
FCS at a final concentration of 20%, agar (Difco Laboratories, Detroit, MI) at a final
concentration of 0.3%, rhGM-CSF at concentrations varying between 10 pg and I ng/ml,
rhIL-3 and rhG-CSF at concentrations between 0.01 and 10 U/ml, rhM-CSF at concen-
trations between 0.1 and 50 U/ml, rhIL-la at concentrations between 10 pg and 10
ng/ml, respectively. For the assays in chemically defined medium, cells were plated in 35-CARACCIOLO ET AL.
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TABLE I
Effect ofrhM-CSF on Human and MouseBone Marrow Progenitor Cells
2.5 x 10' cells/ml and 6 x 10' cells/ml were plated in the human and murine assay, respectively.
* Colonies were scored at day 10 for the mouse assay and at day 14 for the human assay. Numbers
are mean ± SD of triplicate plates. Values refer to one representative experiment of six cases
tested.
$ Number ofcells per colony.
mm petri dishes in 1 ml of HB-102 chemically defined medium (DuPont, Westwood, MA)
supplemented with L-glutamine 0.35 mg/ml (Flow Laboratories, McLean, VA), sodium
pyruvate 1 mM (Flow Laboratories) and agar 0.3% final; cell number per plate and
growth factor concentrations were exactly the same as for the experiments in the presence
of FCS. Cultures were incubated at 37°C, in a humidified incubator at 5% C02. In some
experiments GM-CSF was incubated with the cells in 1 ml of IMDM/20% FCS in Falcon
plastic tubes at 37°C ; after 24 h cells were washed twice in PBS and plated with or without
M-CSF as described above. Experiments were performed on marrow samples from six
different donors in triplicate plates, and treated in exactly the same way. Colonies were
scored after 14 d of culture in the human assay, and after 10 d of culture in the murine
assay. To determine the cellular composition of the resulting colonies, entire agar dishes
were fixed in formal calcium (formalin, 3.7% ; CaCl2, 10 mg/ml) for 10 min, transferred
to a slide, and stained with nonspecific esterase (NSE) and chloroacetate esterase (CAE)
(33, 34).
Results
The recombinant human M-CSF expressed in CHO cells, as reported for other
M-CSF preparations, proved to be much more effective in supporting murine
than human macrophage colony formation (Table I). When adherence-depleted
murine bone marrow cells were plated in the presence of different concentrations
of M-CSF between 0.1 and 50 U/ml, an optimal concentration of 20 U/ml was
observed, which yielded a mean of 68 colonies per plate, with an average size of
100-300 cells/colony. In contrast, <10 colonies/plate were observed at any
concentration of M-CSF in cultures of human bone marrow cells that were
depleted of both adherent cells and T lymphocytes. Bone marrow depleted of
adherent cells but not of T cells gave similar scores (data not shown). All of the
observed human macrophage colonies in these cultures consisted of aggregates
of not more than 50 cells.
To test for enhancement of M-CSF-dependent human macrophage colony
formation, human marrow cells were cultured in the presence of varying con-
centrations of M-CSF, and with several different doses of either GM-CSF, IL-3,
or IL-la. As shown in Fig. 1 A, subliminal concentrations of GM-CSF (in the
range of picograms per milliliter) in combination with M-CSF at >_ 10 U/ml
rhM-CSF
Colonies*
Mouse
Colony
size$ NSE+/CAE- Colonies*
Human
size*
Colony NSE*/CAE-
U/mL % 30
0 0 - - 4 ± 2 40-50 100
1 7 ± 3 50-150 100 7 ± 2 40-50 100
10 57 ± 8 100-250 97 9 t 3 40-50 100
20 68 ± 9 100-300 95 9 ± 5 40-50 100
50 81 t 11 100-300 95 6 ± 3 40-50 1001854GROWTH FACTOR PRIMING OF HUMAN MACROPHAGE PROGENITORS
FIGURE 1.
￿
Effect of rhGM-CSF (A), rhG-CSF (B), rhIL-3 (G), and rhIL-1a (D) at various
concentrations in combination with different concentrations of rbM-CSF on human bone
marrow progenitor cells. A: (0), 0 pg/ml; (O), 10 pg/ml; (11), 100 pg/ml GM-CSF . B: (9), 0
U/ml ; (O), 0.01 U/ml; ("), 0.1 U/ml; (D), 1 U/ml, (A), 10 U/ml G-CSF. C: ("), 0 U/ml ; (O),
0.01 U/ml ; (8), 0.1 U/ml ; (o), 1 U/ml; (A), 10 U/ml IL-3 . D: (0), 0 pg/ml; (O), to pg/ml;
(0), 100pg/ml ; (C1), 1 ng/ml ; (A), 10 ng/ml IL-Ia. Data are given as mean oftriplicate values .
Bars indicate SD . Cells, separated as described in Materials and Methods, were plated at a
final density of 2.5 x 10' cells/ml . Colonies (aggregates of >_40 cells) were scored at day 14 of
culture .
yielded more macrophagic colonies than achieved with any concentrations ofM-
CSF alone. Neither G-CSF (Fig . 1 B), nor IL-3 (Fig . 1 C), nor IL-la (Fig . I D)
showed any significant interaction with M-CSF in enhancing the numbers of
colonies observed, and neither factor had any effect on the observed colony
morphology .
More detailed analysis of the colonies in the GM-CSF-containing cultures
revealed that GM-CSF and M-CSF act synergistically to enhance the formation
of macrophagic colonies that stain positively for NSE (Table II) . GM-CSF at
concentrations below 1 ng/ml combined with any concentration of M-CSF gave
100% NSE'/CAE- colonies . At 1 ng/ml of GM-CSF, the effect on M-CSF-
dependent colony formation was also evident, but was partially masked by the
emergence of conspicuous numbers of other colony types presumed to be due
to stimulation of other GM-CSF-dependent progenitors . Although significant
numbers of both granulocytic (CAE') and mixed granulocytic/macrophagic
(CAE'/NSE') colonies were obtained in the presence of I ng/ml GM-CSF, the
percentage of macrophagic (NSE'/CAE-) colonies was increased in combination
with concentrations of M-CSF of ?10 U/ml . The enhancement of M-CSF-
dependent colony formation was also evident in the colony size; M-CSF alone
yielded small colonies of40-50 cells, but in combination with GM-CSF, colonies
containing up to 300 cells were commonly observed (Table II) .
To determine if subliminal doses of GM-CSF were required throughout the
culture period or if the factor might exert its effects through briefexposure to
the progenitors, we pretreated bone marrow cells in suspension for 24 h with
both M-CSF and GM-CSF, washed the cells, then replated them in semisolidCARACCIOLO ET AL.
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TABLE 11
Synergism of GM-CSF and M-CSF on Macrophagic Colony Formation
2.5 x 104human bone marrow cells, separatedas describedin Materialsand Methods, were plated.
* Colonies were scored after 14 d of culture; numbers are mean t SD of triplicate plates. Values
refer to arepresentative experiment of six different casestested.
$ Number ofcells percolony.
§ Values expressedas percent positive colonies.
TABLE III
Requirementfor Continuous Presence ofSubliminal Concentration of
GM-CSF in M-CSF-Induced Macrophagic Colonies
Cells were incubated at 37°C in the presence of GM-CSF at the given
concentrations. After 24 h cells were washed twice in PBS and plated in
the presence of M-CSF at the given concentration with or without GM-
CSF. Colonies were scored after 14 d of culture. Values are mean t SD
of triplicate plates. Values refer to one representative experiment of six
cases tested. 100% of colonies in every condition stained NSE*/CAE-.
mediumeither in M-CSF aloneor in thepresence ofbothfactors. Assummarized
in Table 111, 24 h exposure ofprogenitors to GM-CSF had little or no effect on
M-CSF-induced colony formation except at the highest concentration tested,
suggesting that the M-CSF-responsive cells may require GM-CSFthroughout the
culture period. The same qualitative effect could be obtained also in serum-free
conditions, although higher doses ofGM-CSF (1-10 ng/ml) were required (data
not shown).
GM-CSF M-CSF Colonies*
(day 14)
Colony*
size NSE*/CAE-§ NSE-/CAE*§ NSE*/CAE* §
pg/ml U/ml
0 1 0 - 0 0 0
0 10 3 t 2 40-50 100 0 0
0 50 8 t 5 40-50 100 0 0
10 0 8 t 4 40-50 100 0 0
10 1 23 ± 7 40-80 100 0 0
10 10 35 t 9 50-150 100 0 0
10 50 58 t 11 100-200 100 0 0
100 0 28 t 11 40-80 100 0 0
100 1 47 t 13 50-150 95 2 3
100 10 93 t 19 50-200 98 1 1
100 50 116 t 31 100-300 100 0 0
1,000 0 156t 34 50-150 27 41 32
1,000 1 163 t 25 50-150 37 35 28
1,000 10 190t 43 50-250 48 26 26
1,000 50 228 t 54 50-300 55 22 23
GM-CSF, 10 pg + M-CSF, 50 U 58 1 11 9 1 2
GM-CSF, 100 pg + M-CSF, 50 U 116 1 31 7 1 4
M-CSF, 50 U (control) 8 1 5 8 ± 5
Continuous GM-CSF
CSFadded presence removed
of GM-CSF after 24 h
GM-CSF, 10 pg 8 t 4 8 t 3
GM-CSF, 100 pg 28 t 11 8t 51856 GROWTH FACTOR PRIMING OF HUMAN MACROPHAGE PROGENITORS
Because GM-CSF has been shown to induce M-CSF production by human
monocytic cells (35), we tested the possibility that pure macrophagic colonies in
a colony assay supported by relatively high concentration (1-10 ng/ml) ofGM-
CSF arise as a secondary effect of M-CSF production in the culture. A neutral-
izing polyclonal antiserum against M-CSF proved to neutralize M-CSF colony
formation in a murine colony assay had no effect on the growth ofmacrophagic
colonies in cultures ofhuman marrow progenitors grown in the presence ofGM-
CSF (data not shown). Thus, GM-CSF by itself at the relatively high concentra-
tions that are usually used in clonogenic assays seems to be capable ofsupporting
the proliferation ofat least some ofthe late progenitors per se ofthe macrophage
lineage.
Discussion
Human M-CSF, either the recombinant protein derived from two different
sources or the natural molecule isolated from human urine, has proved to be
ineffective in supporting human macrophage colony formation, although it is
very efficient in generating murine macrophage colonies (26-29). We have
foundthathuman macrophagic colonies can be generatedeffectivelyifsubliminal
concentrations ofGM-CSF are included in the M-CSF-supported cultures; in this
system the human macrophagic colony formation was as efficient as observed
previously in cultures of murine bone marrow cells. This synergistic activity
between M-CSFandGM-CSF insupport ofhuman macrophagecolony formation
was specific for GM-CSF and was not observed with IL-3, G-CSF, or IL-la.
These results suggest that in the human marrow there is a population of
hemopoietic progenitors that must be primed by exposure to GM-CSF before
they become competent to respond to M-CSF. Our data indicate that concentra-
tions of GM-CSF 100-fold lower than the threshold concentration required to
support colony formation are sufficient to prime the macrophage precursors for
responsiveness to M-CSF. This priming of macrophage precursors requires
exposure to GM-CSF for longer than 24 h (or perhaps continuous exposure),
because washing cells pretreated with GM-CSF before culture in the presence of
M-CSF largely prevented subsequent macrophage colony formation.
The effects of subliminal concentrations of GM-CSF in the human bone
marrow cultures suggest two possible explanations for the different responses of
macrophage progenitors to M-CSF in the human and murine systems. The first
possibility is that in the mouse marrow a large fraction of progenitor cells are
already preprimed by GM-CSF or by 1L-la/H1 to respond to M-CSF. Alterna-
tively, because murine bone marrow samples are usually plated without T cell
depletion (at present no satisfactory techniques have been developed for T cell
depletion in the mouse), it is possible that T cells or even other accessory cells in
the murine cultures elaborate sufficient GM-CSF to prime the macrophage
progenitors for responsiveness to M-CSF. This possibility should be testable with
a neutralizing antibody to murine GM-CSF. Similarly, the demonstration that
monocytes activated with either phorbol myristate acetate or IFN-y express M-
CSF (36) and that GM-CSF itself can induce the expression ofM-CSF transcripts
by monocytes (35) led us to speculate that the macrophagic component of the
GM-CSF activity might be an indirect consequence of the expression of M-CSFCARACCIOLO ET AL.
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FIGURE 2.
￿
Modelofsequential stimulation ofdif-
ferent growth factors on human bone marrow
GM-csF
￿
progenitor cells. A very immature progenitor
M-CSF
￿
(CFU-GEMM, pluripotent stem cell)becomescom-
other
￿
other
￿
mitted to the myeloid lineagebyan ancestral factor
growth factors
￿
lineages
￿
such as IL-3. This early CFU-GM acquires the
ability to respond to GM-CSF, an interaction that
might prime this cell to become a late CFU-GM,
responsive notonly to GM-CSF,butalso to M-CSF
and/or other growth factors. Either high (nano-
gram range) or low (picogram range) concentra-
tions of GM-CSF in the presence of M-CSF could
determine the final macrophagic morphology of
this cell; the interaction with GM-CSF might also
induce this terminal element to produce its own
lineage-specific factor.
in the culture. Ourexperiments withan M-CSF-blocking antiserum in the human
cultures demonstrated that the production ofextracellular M-CSF by cells in the
culture was not necessary for the formation of GM-CSF-supported macrophage
colonies (although we cannot eliminate the possibility that M-CSF produced
within a macrophage precursor that never leaves the cell might be necessary).
These results suggest that GM-CSF exerts two separate effects on macrophage
progenitors (or on different populations of progenitors). At subliminal concen-
trations for direct colony formation, GM-CSF primes at least some macrophage
progenitors to become M-CSF responsive, while at higher concentrations it will
directly support colony formation by at least some of the macrophage progeni-
tors.
We have placed these experimental observations into a general model of
sequential stimulation of the hemopoietic progenitors by different regulatory
molecules in accordance with the stochastic model proposed by Metcalf for the
murine system (3, 4). As shown in Fig. 2, a very ancestral factor, such as IL-3,
could induce a multipotent cell to differentiate to a pluripotent cell capable of
responding to GM-CSF. At this point, the progenitor becomes committed to the
myeloid lineage, but within this lineage still retains the capacity to progress
towards several subclasses such as the neutrophilic granulocytic, the monocytic,
or the eosinophilic pathways. Contact with GM-CSF would make the cell com-
petent for the lineage-restricted factors such as M-CSF or G-CSF. That is, the
GM-CSF exposure would push the individual progenitor into a more mature
state, as evidenced by acquiring theability torespond to the more specific growth
and differentiation factors. At this point, the progenitor (or perhaps progenitor
subsets) might be induced to mature into macrophages by either oftwo different
mechanisms: (a) direct induction by very high concentrations ofGM-CSF; or (b)
indirect induction by low concentrations ofGM-CSF in the presence of M-CSF.
The terminal macrophage in turn mightamplify these signalsbyproducing more
M-CSF under the stimulus ofGM-CSF. It will certainly be of interest to test this
model and to determine if similar growth factor interactions operate in the
murine system to support murine macrophage colony formation.1858 GROWTH FACTOR PRIMING OF HUMAN MACROPHAGE PROGENITORS
Summary
Human macrophage colony-stimulating factor (M-CSF or CSF-1), either in
ified or in recombinant form, is able to generate macrophagic colonies in a
rive bone marrow colony assay, but only stimulates small macrophagic colo-
s of 40-50 cells in a human bone marrow colony assay. We report here that
recombinant human granulocytic/macrophage colony-stimulating factor (rhGM-
CSF) at concentrations in the range ofpicograms enhances the responsiveness of
bone marrow progenitors to M-CSF activity, resulting in an increased number
ofmacrophagic colonies of up to 300 cells. Polyclonal antiserum against M-CSF
did not alter colony formation ofbone marrow progenitors incubated with GM-
CSF at optimal concentration (1-10 ng/ml) for these in vitro assays. Thus, GM-
CSF at higher concentrations (nanogram range) can by itself, elicit macrophagic
colonies, and at lower concentrations (picogram range) acts to enhance the
responsiveness ofthese progenitors to M-CSF
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